In Heart attack Retefast Kit dissolves harmful blood clots that cause heart attack (if they are in the heart). They also dissolve clots that form in other blood vessels. This means that blood can again start to flow freely through your body. This medicine will, therefore, reduce both the damage caused by, and the risk of dying from a heart attack. The sooner the injection is given, the greater are the chances of recovery.
It is not known whether it is safe to consume alcohol with Retefast Kit. Please consult your doctor.
Retefast Kit may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Retefast Kit is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Not relevant, as Retefast Kit is intended for use in hospitalised patients.
Retefast Kit should be used with caution in patients with kidney disease. Dose adjustment of Retefast Kit may be needed. Please consult your doctor. Use of Retefast Kit is not recommended in patients with severe kidney disease.
Retefast Kit should be used with caution in patients with liver disease. Dose adjustment of Retefast Kit may be needed. Please consult your doctor. Use of Retefast Kit is not recommended in patients with severe kidney disease.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Lupin Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Cipla Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Biochem Pharmaceutical Industries || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Reliance Life Sciences || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Emcure Pharmaceuticals Ltd || ₹14.5/tablet (25% cheaper)